The preliminary numbers for 2018 look really bad. If I was the board, Rami would be getting a lot of tough questions. His plan has been schizophrenic which is why he needs a VP.
Originally the goal was to slowly expand the sales team so the reps could build the business by growing customers SCS practices. Then everyone quit or were fired. Next they had to hire replacements. Then those reps quit or were fired. And again it happened. Now it seems like they are expanding more than just the reps they need to replace.
The SCS business is dog eat dog. I honestly don't believe surgeons think there is a big enough difference between products so price and rep continuity will be the key to maintaining and growing the business.
With all the layoffs and reps leaving, is it possible to keep a high level of continuity in the sales team? Based on what I'm seeing, no. Next, can we compete on price? Nope again.
Growth is done at Nevro unless a product comes out that I haven't heard about.